DE3674567D1 - Verbesserungen in bezug auf nachweis von viren und antikoerpern. - Google Patents

Verbesserungen in bezug auf nachweis von viren und antikoerpern.

Info

Publication number
DE3674567D1
DE3674567D1 DE8686901949T DE3674567T DE3674567D1 DE 3674567 D1 DE3674567 D1 DE 3674567D1 DE 8686901949 T DE8686901949 T DE 8686901949T DE 3674567 T DE3674567 T DE 3674567T DE 3674567 D1 DE3674567 D1 DE 3674567D1
Authority
DE
Germany
Prior art keywords
antibody detection
improvements regarding
regarding virus
virus
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686901949T
Other languages
English (en)
Inventor
David Griffiths
Elizabeth Grundy
A Mckeating
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Free Hospital School of Medicine
Original Assignee
Royal Free Hospital School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506942A external-priority patent/GB8506942D0/en
Priority claimed from GB858513211A external-priority patent/GB8513211D0/en
Application filed by Royal Free Hospital School of Medicine filed Critical Royal Free Hospital School of Medicine
Application granted granted Critical
Publication of DE3674567D1 publication Critical patent/DE3674567D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8686901949T 1985-03-18 1986-03-17 Verbesserungen in bezug auf nachweis von viren und antikoerpern. Expired - Lifetime DE3674567D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858506942A GB8506942D0 (en) 1985-03-18 1985-03-18 Detection of viruses
GB858513211A GB8513211D0 (en) 1985-05-24 1985-05-24 Detection of virus antibodies
PCT/GB1986/000155 WO1986005593A1 (en) 1985-03-18 1986-03-17 Improvements relating to the detection of viruses and antibodies

Publications (1)

Publication Number Publication Date
DE3674567D1 true DE3674567D1 (de) 1990-10-31

Family

ID=26288991

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686901949T Expired - Lifetime DE3674567D1 (de) 1985-03-18 1986-03-17 Verbesserungen in bezug auf nachweis von viren und antikoerpern.

Country Status (5)

Country Link
US (1) US4937199A (de)
EP (1) EP0229767B1 (de)
AU (1) AU593795B2 (de)
DE (1) DE3674567D1 (de)
WO (1) WO1986005593A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
US5420013A (en) * 1991-05-10 1995-05-30 Sangstat Medical Corporation HLA typing
US5256543A (en) * 1991-05-10 1993-10-26 Sangstat Medical Corporation HLA typing
DE69231660T2 (de) 1991-08-15 2001-06-21 Sangstat Medical Corp., Menlo Park Hla-typisierung von humanen leukozyten
JP2799835B2 (ja) * 1995-01-31 1998-09-21 第一化学薬品株式会社 コレステロールの定量方法
WO2018158618A1 (es) 2017-03-03 2018-09-07 Universidad De La Frontera Kit de detección de enfermedades de transmisión sexual silentes (etss) en muestra de orina

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154599B (nl) * 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
US4341754A (en) * 1980-01-24 1982-07-27 Vanderbilt University Diagnostic reagent for herpes simplex virus encephalitis
EP0051985B2 (de) * 1980-11-07 1989-12-27 International Institute Of Cellular And Molecular Pathology (Icp) Immunologischer Test von Proteinen
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
FR2519650B1 (fr) * 1982-01-13 1985-07-12 Univ Paris Curie Lignees cellulaires hybrides murines anti-herpes, procede d'obtention, anticorps monoclonaux anti-herpes, applications biologiques
SE8203909L (sv) * 1982-06-23 1983-12-24 Britta Wahren Bestemning av virus kenslighet for antivirala medel
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US4617264A (en) * 1983-11-04 1986-10-14 Syntex (U.S.A.) Inc. Pretreatment method and composition
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US4675286A (en) * 1985-01-28 1987-06-23 Aspen Diagnostics, Inc. Fetal cell separation and testing

Also Published As

Publication number Publication date
AU5627786A (en) 1986-10-13
US4937199A (en) 1990-06-26
EP0229767B1 (de) 1990-09-26
AU593795B2 (en) 1990-02-22
WO1986005593A1 (en) 1986-09-25
EP0229767A1 (de) 1987-07-29

Similar Documents

Publication Publication Date Title
DE3855790D1 (de) Nachweis von Ionen in Flüssigkeiten
DE3672335D1 (de) Foerderanordnung von luft.
DE3675824D1 (de) Antianaphylaktische und antibronchospastische n-benzhydrylcycloalkylalkananilide.
DE3680816D1 (de) Abtast- und haltestromkreis.
DE69023172D1 (de) Plasmaseparations- und Plasmasammelvorrichtung von Single-Needle-Typ.
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
DE3679764D1 (de) Zaepfchen und grundlage dafuer.
DE3788807D1 (de) Fusionsproteine und -partikel.
DE3671533D1 (de) Immunotestverfahren und reagenz dafuer.
DE3677916D1 (de) Nachweis von retikulozyten.
DE3673928D1 (de) Nachweis von retikulocyten.
NO862934L (no) Herbicid samt anvendelse derav.
DE3673430D1 (de) 7-amino-4-methyl-coumarin-3-carboxyalkyl-abkoemmlinge und fluoreszierende konjugate daraus.
DE3674567D1 (de) Verbesserungen in bezug auf nachweis von viren und antikoerpern.
DE3685413D1 (de) Insektizide und viren.
BR8701883A (pt) Sistema de escrita dirigida e conjunto de representacao visual variavel
DE3685315D1 (de) Antivirus-heilmittel.
DE3689144D1 (de) Pseudorabiesvirus-Protein.
DE3771768D1 (de) Nachweismethode und geraet.
ATE48275T1 (de) Cardiotonische heterocyclocarbonyl- und acetylthiazolone.
ATE57019T1 (de) Verbesserungen in bezug auf nachweis von viren und antikoerpern.
DE58908995D1 (de) Immunologischer Nachweis von Atrazin und Atrazinderivaten.
FI871329A (fi) Anordning foer haoldrivning i haorda bergarter.
DE3852191D1 (de) Polyethylenterephthalat und Verwendungen davon.
ATE57262T1 (de) Verfahren zum nachweis von proteinen und viren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee